|
| |
Polyclone Bioservices is a molecular biology and genomics company that synergistically combines in vitro and in silico approaches to address target and biomarker discovery & validation challenges. We work with Bio-Supply, Biotech Platform and Drug Discovery companies and help them
cost effectively achieve their research and product goals in quicker
time.
Polyclone is headquartered in Bangalore, India with operations in Europe and the US. |
| |
 |
|
|
| |
Through our “extended team” model, we enable our customers to better plan their project outcomes, increase their organizational efficiency and maximize their investments by providing access to a pool of scientists with expertise in both wet-lab and in-silico aspects of qPCR, microarrays, mass-spec based genotyping & proteomics, RNAi and miRNA.
|
|
|
| |
|
| |
|
|
|
|
|
| |
Naveen Kulkarni, CEO, Polyclone Bioservices, shares his views on marketing challenges faced by biotech industry in BioSpectrum cover story
click here
|
| |
Pharma Express:‘Indian pharma industry must focus on becoming a powerhouse of innovation'
click here
|
| |
|
|
 |
|
| |
|
|
| |
|
|
| |
View All |
|
| |
|
|
|